Updated

Protagonist Therapeutics reported a swing to profitability as two of its drug candidates near blockbuster sales potential. The biotech's results reflect progress in its clinical and commercial pipeline. Investors reacted positively to signs that the company's pipeline is maturing into meaningful revenue-generating products.